Kathleen S Bingham
Overview
Explore the profile of Kathleen S Bingham including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
127
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Flint A, Bingham K
Int Psychogeriatr
. 2025 Feb;
37(1):100023.
PMID: 39924268
No abstract available.
2.
Ihaddadene R, Alexopoulos G, Marino P, Meyers B, Mulsant B, Neufeld N, et al.
Psychiatry Res
. 2024 Sep;
342:116192.
PMID: 39299145
Little is known about factors that contribute to attrition in clinical trials of the pharmacotherapy of psychotic depression. The purpose of this study was to identify factors associated with attrition...
3.
Kim H, Voineskos A, Neufeld N, Alexopoulos G, Bingham K, Flint A, et al.
Mol Psychiatry
. 2024 Mar;
29(8):2459-2466.
PMID: 38503927
Some data suggest that antipsychotics may adversely affect brain structure. We examined the relationship among olanzapine exposure, relapse, and changes in brain structure in patients with major depressive disorder with...
4.
Tani H, Moxon-Emre I, Forde N, Neufeld N, Bingham K, Whyte E, et al.
Brain Imaging Behav
. 2023 Nov;
18(1):117-129.
PMID: 37917311
Background: The neurobiology of psychotic depression is not well understood and can be confounded by antipsychotics. Magnetic resonance spectroscopy (MRS) is an ideal tool to measure brain metabolites non-invasively. We...
5.
Banerjee S, Wu Y, Bingham K, Marino P, Meyers B, Mulsant B, et al.
Psychol Med
. 2023 Oct;
54(6):1142-1151.
PMID: 37818656
Background: Remitted psychotic depression (MDDPsy) has heterogeneity of outcome. The study's aims were to identify subgroups of persons with remitted MDDPsy with distinct trajectories of depression severity during continuation treatment...
6.
Neufeld N, Oliver L, Mulsant B, Alexopoulos G, Hoptman M, Tani H, et al.
Mol Psychiatry
. 2023 May;
28(8):3305-3313.
PMID: 37258617
The effect of antipsychotic medication on resting state functional connectivity in major depressive disorder (MDD) is currently unknown. To address this gap, we examined patients with MDD with psychotic features...
7.
Bingham K, Calarco N, Dickie E, Alexopoulos G, Butters M, Meyers B, et al.
J Affect Disord
. 2023 May;
334:317-324.
PMID: 37149056
Background: Psychomotor disturbance is common in psychotic depression and is associated with relapse. In this analysis, we examined whether white matter microstructure is associated with relapse probability in psychotic depression...
8.
Flint A, Bingham K, Alexopoulos G, Marino P, Mulsant B, Neufeld N, et al.
J Psychiatr Res
. 2022 Dec;
157:285-290.
PMID: 36535116
Psychotic depression has a high rate of relapse. The study aims were to identify a prediction model of risk of relapse of psychotic depression and examine whether predictors moderated the...
9.
Haslam-Larmer L, Grigorovich A, Quirt H, Engel K, Stewart S, Rodrigues K, et al.
Dementia (London)
. 2022 Oct;
22(1):5-27.
PMID: 36240074
Healthcare providers caring for people living with dementia may experience moral distress when faced with ethically challenging situations, such as the inability to provide care that is consistent with their...
10.
Dobrowolski C, McGinley J, Fazzari M, Su J, Bingham K, Anderson N, et al.
Rheumatology (Oxford)
. 2022 Sep;
62(5):1860-1869.
PMID: 36135792
Objectives: Cognitive dysfunction (CD) is a common manifestation of SLE that can have detrimental consequences for those affected. To date, no treatments have been approved for SLE-CD. This study aims...